137 related articles for article (PubMed ID: 35344641)
1. Radiomic features as biomarkers of soft tissue paediatric sarcomas: preliminary results of a PET/MR study.
Giraudo C; Fichera G; Stramare R; Bisogno G; Motta R; Evangelista L; Cecchin D; Zucchetta P
Radiol Oncol; 2022 Mar; 56(2):138-141. PubMed ID: 35344641
[TBL] [Abstract][Full Text] [Related]
2. Tumor cellularity beyond the visible in soft tissue sarcomas: Results of an ADC-based, single center, and preliminary radiomics study.
Giraudo C; Fichera G; Del Fiore P; Mocellin S; Brunello A; Rastrelli M; Stramare R
Front Oncol; 2022; 12():879553. PubMed ID: 36303833
[TBL] [Abstract][Full Text] [Related]
3. Soft Tissue Sarcomas: Preoperative Predictive Histopathological Grading Based on Radiomics of MRI.
Zhang Y; Zhu Y; Shi X; Tao J; Cui J; Dai Y; Zheng M; Wang S
Acad Radiol; 2019 Sep; 26(9):1262-1268. PubMed ID: 30377057
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
Schwarzbach MH; Dimitrakopoulou-Strauss A; Willeke F; Hinz U; Strauss LG; Zhang YM; Mechtersheimer G; Attigah N; Lehnert T; Herfarth C
Ann Surg; 2000 Mar; 231(3):380-6. PubMed ID: 10714631
[TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.
Younis MH; Abu-Hijleh HA; Aldahamsheh OO; Abualruz A; Thalib L
Med Princ Pract; 2020; 29(5):465-472. PubMed ID: 31887730
[TBL] [Abstract][Full Text] [Related]
6. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
Dancheva Z; Bochev P; Chaushev B; Yordanova T; Klisarova A
Nucl Med Rev Cent East Eur; 2016; 19(1):22-7. PubMed ID: 26841376
[TBL] [Abstract][Full Text] [Related]
7. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
Bastiaannet E; Groen H; Jager PL; Cobben DC; van der Graaf WT; Vaalburg W; Hoekstra HJ
Cancer Treat Rev; 2004 Feb; 30(1):83-101. PubMed ID: 14766127
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S
BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449
[TBL] [Abstract][Full Text] [Related]
9. PET/CT and PET/MR in Soft Tissue Sarcoma: An Update.
Khalatbari H; Shulkin BL; Parisi MT
Semin Nucl Med; 2024 May; 54(3):313-331. PubMed ID: 38423851
[TBL] [Abstract][Full Text] [Related]
10. Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest.
Yang Y; Ma X; Wang Y; Ding X
Updates Surg; 2022 Feb; 74(1):355-365. PubMed ID: 34003477
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.
Charest M; Hickeson M; Lisbona R; Novales-Diaz JA; Derbekyan V; Turcotte RE
Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1944-51. PubMed ID: 19593561
[TBL] [Abstract][Full Text] [Related]
12. Natural Changes in Radiological and Radiomics Features on MRIs of Soft-Tissue Sarcomas Naïve of Treatment: Correlations With Histology and Patients' Outcomes.
Fadli D; Kind M; Michot A; Le Loarer F; Crombé A
J Magn Reson Imaging; 2022 Jul; 56(1):77-96. PubMed ID: 34939705
[TBL] [Abstract][Full Text] [Related]
13. Does Advanced Imaging Have a Role in Detecting Local Recurrence of Soft-tissue Sarcoma?
England P; Hong Z; Rhea L; Hirbe A; McDonald D; Cipriano C
Clin Orthop Relat Res; 2020 Dec; 478(12):2812-2820. PubMed ID: 32667755
[TBL] [Abstract][Full Text] [Related]
14. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
15. CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy.
Peeken JC; Bernhofer M; Spraker MB; Pfeiffer D; Devecka M; Thamer A; Shouman MA; Ott A; Nüsslin F; Mayr NA; Rost B; Nyflot MJ; Combs SE
Radiother Oncol; 2019 Jun; 135():187-196. PubMed ID: 30961895
[TBL] [Abstract][Full Text] [Related]
16. Tumor grade in soft-tissue sarcoma: Prediction with magnetic resonance imaging texture analysis.
Hong JH; Jee WH; Jung CK; Chung YG
Medicine (Baltimore); 2020 Jul; 99(27):e20880. PubMed ID: 32629676
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography of soft tissue sarcomas.
Israel-Mardirosian N; Adler LP
Curr Opin Oncol; 2003 Jul; 15(4):327-30. PubMed ID: 12874512
[TBL] [Abstract][Full Text] [Related]
18. Soft Tissue Sarcoma Response to Two Cycles of Neoadjuvant Chemotherapy: A Multireader Analysis of MRI Findings and Agreement with RECIST Criteria and Change in SUVmax.
Favinger JL; Hippe DS; Davidson DJ; Elojeimy S; Roth ES; Lindberg AW; Ha AS
Acad Radiol; 2018 Apr; 25(4):470-475. PubMed ID: 29273189
[TBL] [Abstract][Full Text] [Related]
19. Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade and Patient Outcome.
Crombé A; Marcellin PJ; Buy X; Stoeckle E; Brouste V; Italiano A; Le Loarer F; Kind M
Radiology; 2019 Jun; 291(3):710-721. PubMed ID: 30964422
[TBL] [Abstract][Full Text] [Related]
20. Tumor grading of soft tissue sarcomas using MRI-based radiomics.
Peeken JC; Spraker MB; Knebel C; Dapper H; Pfeiffer D; Devecka M; Thamer A; Shouman MA; Ott A; von Eisenhart-Rothe R; Nüsslin F; Mayr NA; Nyflot MJ; Combs SE
EBioMedicine; 2019 Oct; 48():332-340. PubMed ID: 31522983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
